FILE:HCP/HCP-8K-20110215083304.txt.gz
EVENTS:	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers	Regulation FD Disclosure	Financial Statements and Exhibits
TEXT:
ITEM: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM: Regulation FD Disclosure
ITEM: Financial Statements and Exhibits
 
 
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
o
 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o
       Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o
       Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o
       Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Item 5.02(b)       Departure of Directors.
 
On February 10, 2011, Harold M. Messmer, Jr., advised the Board of Directors of HCP, Inc. (the "Company") that he intends to retire from the Board and not seek re-election when his term expires at the Company's upcoming 2011 Annual Meeting of Stockholders. Mr. Messmer has been a member of the Board of Directors since the Company's initial public offering over 25 years ago.
 
Item 7.01       Regulation FD Disclosure.
 
On February 15, 2011, the Company issued a press release, attached as Exhibit 99 to this Form 8-K, announcing the retirement of Mr. Messmer from its Board of Directors.  The information set forth in this Item 7.01 of this Form 8-K, including the text of the press release, attached as Exhibit 99, hereto, is being furnished to, but not filed with, the Securities and Exchange Commission.
 
Item 9.01       Financial Statements and Exhibits.
 
(d)           Exhibits. The following exhibits are being filed herewith:
 
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 

Exhibit 99
 
 
HCP ANNOUNCES RETIREMENT OF DIRECTOR
 
LONG BEACH, CA  February 15, 2011  HCP, Inc. (NYSE: HCP) today announced that Harold M. Messmer, Jr., a Director of HCP, has advised the Board of Directors that he intends to retire from the Board and not seek re-election when his term expires at HCP's upcoming 2011 Annual Meeting of Stockholders.
 
"Max has been a dedicated member of HCP's Board of Directors since the Company's IPO over 25 years ago," said Jay Flaherty, HCP's Chairman and Chief Executive Officer.  "His leadership and expertise have contributed to HCP's successful growth.  On behalf of our Board of Directors and HCP, I want to thank Max for his faithful dedication and service to the Company."
 
Mr. Messmer said, "I have been fortunate for the opportunity to have served on such a distinguished Board for a great company since its public inception.  I personally want to thank Jay, our Chairman and CEO, along with the other members of Board for all of their support and I wish them and HCP continued success."
About HCP
 
HCP, Inc., an S&P 500 company, is a real estate investment trust (REIT) that, together with its consolidated subsidiaries, invests primarily in real estate serving the healthcare industry in the United States.  As of December 31, 2010, the Company's portfolio of investments, including properties owned by its Investment Management Platform, consisted of: (i) interests in 672 facilities among the following segments: 251 senior housing, 102 life science, 253 medical office, 45 post-acute/skilled nursing and 21 hospital; and (ii) $2.0 billion of mezzanine and other secured loans.  For more information, visit the Company's website at www.hcpi.com.
 
 
SOURCE:  HCP, Inc.
 
HCP Thomas M. Herzog Executive Vice President - Chief Financial Officer (562) 733-5309
 


